SciELO - Scientific Electronic Library Online

Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivos de Gastroenterologia

Print version ISSN 0004-2803

Arq. Gastroenterol. vol.51 no.3 São Paulo June/Sept. 2014 

Original Articles


Malignidade em grandes lesões colorretais

Carlos Eduardo Oliveira dos SANTOS1 

Daniele MALAMAN1 

Tiago dos Santos CARVALHO1 

César Vivian LOPES2 

Júlio Carlos PEREIRA-LIMA2 

1Departamento de Gastroenterologia e Endoscopia Digestiva, Hospital Santa Casa, Bagé, RS

2Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, RS, Brasil



The size of colorectal lesions, besides a risk factor for malignancy, is a predictor for deeper invasion


To evaluate the malignancy of colorectal lesions ≥20 mm.


Between 2007 and 2011, 76 neoplasms ≥20 mm in 70 patients were analyzed


The mean age of the patients was 67.4 years, and 41 were women. Mean lesion size was 24.7 mm ± 6.2 mm (range: 20 to 50 mm). Half of the neoplasms were polypoid and the other half were non-polypoid. Forty-two (55.3%) lesions were located in the left colon, and 34 in the right colon. There was a high prevalence of III L (39.5%) and IV (53.9%) pit patterns. There were 72 adenomas and 4 adenocarcinomas. Malignancy was observed in 5.3% of the lesions. Thirty-three lesions presented advanced histology (adenomas with high-grade dysplasia or early adenocarcinoma), with no difference in morphology and site. Only one lesion (1.3%) invaded the submucosa. Lesions larger than 30 mm had advanced histology (P = 0.001). The primary treatment was endoscopic resection, and invasive carcinoma was referred to surgery. Recurrence rate was 10.6%.


Large colorectal neoplasms showed a low rate of malignancy. Endoscopic treatment is an effective therapy for these lesions.

Key words: Colonic polyps; Colorectal neoplasms; Gastrointestinal endoscopy



O tamanho em lesões colorretais, além de risco para malignidade, é preditor para invasão profunda.


Avaliar a presença de malignidade em lesões colorretais ≥20 mm.


Entre 2007 e 2011, 76 neoplasias colônicas ≥20 mm em 70 pacientes foram analisadas.


A idade média foi de 67,4 anos, e 41 eram mulheres. O tamanho médio das lesões foi de 24,7 mm ± 6,2 mm, com variação de 20 a 50 mm. Metade das neoplasias foram polipoides e a outra metade, não polipoide. O cólon esquerdo apresentou 42 (55,3%) neoplasias e o direito, 34. Houve alta prevalência de lesões com criptas padrão III L (39,5%) e IV (53,9%). Houve 72 adenomas e 4 adenocarcinomas. Malignidade foi detectada em 5,3% dos casos. Histologia avançada (adenoma com displasia de alto grau ou adenocarcinoma precoce) foi diagnosticada em 33 lesões, sem diferença quanto à morfologia e local da lesão. Apenas uma lesão (1,3%) invadiu a submucosa. Lesões maiores de 30 mm apresentaram histologia avançada (P = 0,001). A ressecção endoscópica foi a terapêutica primária, e carcinoma invasivo foi encaminhado para cirurgia. Recorrência foi de 10,6%.


Grandes neoplasias colorretais demonstram uma baixa taxa de malignidade. A ressecção endoscópica é terapêutica adequada para estas lesões.

Palavras-Chave: Pólipos do colo; Neoplasias colorretais; Endoscopia gastrointestinal


Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. It affects mainly people older than 50 years and its development can be explained either by the adenoma-carcinoma sequence(22), the pathway of the de novo cancer(19, 27), or, more recently, the serrated pathway(24).

The removal of precursor colorectal lesions has enabled a significant reduction in the incidence of cancer, and early detection of CRC reduces mortality(33). The characteristics of the removed lesions and histopathology determine colonoscopic surveillance. A recent guidelines(8) indicates shorter intervals for advanced neoplasms (adenomas ≥10 mm, villous histology or high-grade dysplasia, and cancer). Besides these criteria, the presence of three or more adenomas and serrated polyps ≥10 mm fulfill the requirements for the high-risk group. Thus, large lesions (≥2.0 cm) are considered high risk neoplasms, with potential for malignancy, submucosal invasion and lymphatic involvement. These lesions may be polypoid (sessile, pedunculated and subpedunculated) and non-polypoid (flat lesions and laterally spreading tumors/LST).

Techniques for resection of these large lesions can use a diathermy loop for pedunculated or subpedunculated lesions, and the method of endoscopic mucosal resection or submucosal dissection for sessile and non-polypoid lesions(11, 30).

This study aimed to analyze the characteristics and malignancy rate of large neoplastic colorectal lesions (> 20 mm).


Between January 2007 and December 2011, 76 neoplastic lesions ≥20 mm were diagnosed in 70 patients, corresponding to 3.7% of neoplasms found during this period at our Endoscopy Unit. This study prospective analyzed the characteristics (age, sex, size, morphology, site, pit pattern, histology, grade of dysplasia, recurrence) and the malignancy of these lesions. Lesions are called superficial when their appearence at endoscopy suggests that depht is limited to the mucosa or submucosa. All colonoscopies were performed by the same experienced endoscopist (CEOS). Bowel preparation was performed with a day of clear liquid diet, and a 10% mannitol solution on the day of the exam. Conscious sedation (intravenous midazolam and meperidine or fentanyl) was administered and a high resolution colonoscopy was performed (Fujinon 490ZW5 and 590ZW5, Fujifilm Corp., Saitama, Japan) with progression to the cecum/terminal ileum. The processor used was EPX4400. Exclusion criteria were: inadequate bowel preparation, incomplete colonoscopy, coagulopathy, history or presence of inflammatory bowel disease, polypoid syndromes, presence of advanced cancer, previous surgical colorectal resection, non-neoplastic lesions and lesions smaller than 2.0 cm.

The study was conducted according to the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee of the Hospital Santa Casa de Caridade de Bagé. All patients signed an informed consent prior to colonoscopy. The Paris classification determined the morphology of the lesions(31). Lesion size was estimated by open biopsy forceps with an opening of 8 mm between its claws (FB 24U-1, Olympus Medical Systems Corp., Tokyo, Japan) and, when possible, after its removal. The site was estimated according to the anatomical landmarks. The Kudo classification was chosen as reference standard for the study of pits(12, 13), and indigo carmine was the dye for chromoendoscopy (CE). All lesions were removed in a single session. Pedunculated and subpedunculated lesions were removed by polypectomy snare and non-sessile polypoid lesions were resected by endoscopic mucosal resection (EMR), en bloc (lesions = 20 mm) or piecemeal (lesions >20 mm), and all the material removed was placed in 10% formalin and stained with hematoxylin and eosin for histopathological analysis. Histological diagnosis was defined according to the guidelines of the World Health Organization(7). Advanced histology was defined as presence of high-grade dysplasia or early cancer(26). The cancer was considered advanced when invading the submucosa, and these cases were excluded from the study. In the case of multiple lesions, each lesion was placed in a separate flask. Local recurrence was defined as the presence of neoplastic tissue in the area of previous resection at the control colonoscopy. Follow-up was conducted every 6 months, with a total follow-up of 24 months for lesions underwent endoscopic mucosal resection. Recurrent lesions were removed with a new endoscopic mucosal resection and were identified by the EMR scar. Recurrent lesions were removed with a new endoscopic mucosal resection.

Statistical analysis

Numerical variables were expressed as mean ± standard deviation, and categorical variables were expressed as percentages. Fisher’s exact test was used for comparison between means. The significance level for all the statistical tests was 5%.


The mean age of patients was 67.4 years (± 13.3 years), with 41 women and 29 men. Mean lesion size was 24.7 mm (± 6.2 mm), ranging between 20 and 50 mm. Thirty-eight (50%) lesions were polypoid (10 type 0-Is, 8 type 0-Isp and 20 type 0-Ip) and 38 (50%) lesions were non-polypoid (1 type 0-IIc and 37 laterally spreading tumor/LST). Regarding site, 42 (55.3%) were located in the left colon (15 in the rectum, 22 in the sigmoid and 5 in the descending) and 34 (44.7%) were located in the right colon (4 in the transverse, 19 in the ascending and 11 in the cecum).

Polypoid lesions were more frequent in the left colon (31/38) and non-polypoid lesions were more commonly found in the right colon (27/38). Analyzing the pit patterns, 1 (1.3%) lesion was type II, 29 (38.2%) were type III L, 41 (53.9%) were type IV and 5 (6.6%) were type V. Therefore, 75 (98.7%) lesions ≥20 mm presented a pit pattern compatible with neoplasms (III - V), according to the Kudo classification(12, 13), with a predominance of the villous histologic subtype. The neoplastic lesion with a type II pit pattern, suggestive of a non-neoplastic lesion, was a non-granular LST of the smooth subtype, measuring 25 mm, located in the cecum, and histology showed that it was a sessile serrated adenoma. Among the five type V lesions, however, four lesions were adenocarcinomas and one was an adenoma with high-grade dysplasia. The relationship between pit patterns and histology is shown in Table 1.

TABLE 1. Relationship between pit pattern and histopathology of colorectal neoplasms 

II 0 1 1
III L 7 22 29
IV 21 20 41
V 5 0 5

P = 0.002. Ca: adenocarcinoma; HGD: high-grade dysplasia; TA: tubular adenoma; TVA: tubulo-villous adenoma; VA: villous adenoma; SA: serrated adenoma; LGD: low-grade dysplasia

Histology revealed 72 adenomas (20 tubular, 42 tubulo-villous, 8 villous, and 2 serrated adenomas) and 4 adenocarcinomas (3 intramucosal carcinomas and 1 invasive). Among the adenomas, 29 (40.3%) of the lesions presented high-grade dysplasia. The relationship between the morphological appearance and histology is shown in Table 2. All lesions in this study were superficial lesions. Thirty-three lesions presented advanced histology (adenomas with high-grade dysplasia or adenocarcinoma), affecting three patients under 50 years of age and 28 patients aged 50 years or more. There was no difference in the morphology (15 polypoid versus 18 non-polypoid, P = 0.644) and site (20 in the left colon versus 13 in the right colon, P = 0.358) for these lesions. However, 100%(15) of the polypoid neoplasms with advanced histology were located in the left colon, whereas 72.2% (13/18) of the non-polypoid neoplasms with advanced histology were in the right colon.

TABLE 2. Relationship between the morphology and histopathology of colorectal neoplasms 

Morphology Ca / HGD TA, TVA, VA, SA / LGD TOTAL
Is 5 5 10
Isp 3 5 8
Ip 7 13 20
IIc 1 0 1
LST 17 20 37

P = 0.841. LST: Laterally Spreading Tumor; Ca: adenocarcinoma; HGD: high-grade dysplasia; TA: tubular adenoma; TVA: tubulo-villous adenoma; VA: villous adenoma; SA: serrated adenoma; LGD: low-grade dysplasia

Neoplasms were still divided into two groups according to their size: 20-30 mm and >30 mm. All lesions >30 mm were adenomas with high-grade dysplasia or cancer, while 25 (36.7%) of the remaining 68 lesions with size between 20 and 30 mm presented with advanced histology (P<0.001).

The only invasive cancer in our study was a non-polypoid, depressed superficial type 0-IIc lesion measuring 25 mm, with type V pit pattern, located in the sigmoid colon and massively invading the submucosa, which was later referred for surgical resection. The remaining 75 neoplastic lesions underwent only endoscopic treatment. Fourty-seven lesions were treated by endoscopic mucosal resection: 24 (51%) lesions were resected en bloc and 23 (49%) lesions were removed using the piecemeal technique.

Resection was considered incomplete when there was evidence of malignancy in lateral or deep margins, which was only found in one lesion. No deaths were associated with endoscopic treatment. Recurrence was observed in five lesions (10.6%), all LST type, without significant difference between en bloc and piecemeal techniques (4.2 vs 17.4%, P = 0.188). Recurrence was observed in five (10.6%) lesions, all LST type removed by the technique of endoscopic mucosal resection and diagnosed at the first control colonoscopy, 6 months after resection. The recurrent lesions were treated with new endoscopic mucosal resection, with complete removal. No new or recurrent lesions were found for the remainder of the follow-up. We had 94 lesions with morphology advanced cancer who were referred to surgery and histopathology demonstrated muscular propria invasion or more, with all these lesions excluded from the study.


Colorectal neoplasms ≥20 mm are considered advanced neoplasms and, therefore, present high risk for progression to cancer. Thus, the interval recommended for colonoscopy surveillance is reduced to 3 years after the first colonoscopy(8). In the group of high-risk lesions (≥10 mm, villous histology or high-grade dysplasia, >2 adenomas and serrated polyps ≥ 10 mm), an increased risk of advanced adenoma and metachronous CRC at the follow-up colonoscopy was observed. Chung et al.(3) have shown a 6-fold higher incidence of metachronous advanced neoplasms for patients in the high-risk group, when compared to individuals without adenomas at the index colonoscopy, considering that the size ≥10 mm is an independent predictor.

Martinez et al.(16) have observed a 15.5% risk of advanced neoplasm during follow-up in the high-risk group and of 6.9% in the low risk group. The risk of invasive cancer was 1.2% in patients who had adenomas ≥20 mm at the index colonoscopy and 1.3% in patients who presented lesions with high-grade dysplasia. Compared to patients with adenomas ≥20 mm at the baseline colonoscopy, the adjusted probability for advanced neoplasm was 2.99.

Studies have shown a strong correlation between lesion size and its potential for malignancy(2, 4, 32), and these lesions are considered to be at higher risk for submucosal invasion and lymph node involvement(9). A greater malignant potential for lesions >10 mm (P<0.0001) was observed by Reinhart et al.(23), regardless of morphology. However, there have been series showing that small, non-polypoid lesions are more likely to contain carcinoma and a deeper infiltration of the submucosa, when compared to larger, polypoid lesions(14, 20, 29). Kurisu et al.(14) have investigated the development and progression of early CRC, and observed that non-polypoid lesions were significantly smaller than polypoid lesions and presented with deeper invasion of the submucosa. Soetikno et al.(29) have also found that non-polypoid lesions were more likely to contain carcinoma (OR = 9.78) than polypoid lesions, regardless of their size. Matsuda et al.(20) have shown a similar aggressiveness and malignant potential when comparing smaller and larger lesions.

In our study, we found four (5.3%) adenocarcinomas among the 76 neoplasms ≥20 mm, and 29 (38.2%) adenomas with high-grade dysplasia. Therefore, 43.4% presented with advanced histology. All adenocarcinomas were located in the left colon, but only one lesion had massively invaded the submucosa (1.3%). In the study by Ahlawat et al.(1), 183 lesions of the colon and rectum ≥20 mm, most of them sessile, were removed endoscopically, and the rate of invasive carcinoma was 10%.

When comparing our polypoid and non-polypoid lesions, no difference was observed in relation to advanced histology. Luigiano et al.(15) have shown increased malignancy in sessile polypoid lesions when compared to non-polypoid, superficial lesions (21.6% versus 6%, P = 0.0013). Another series has examined the risk of lymph node metastases in patients with invasive pedunculated polypoid type CRC. Among the patients that were treated surgically, the incidence of lymph node metastases was 3.5% (8/230); however, the incidence was 0% (0/101) in patients with invasion at the polyp head and 6.2% (8/129) when the invasion occurred at the pedicle of the polyp(18). Caputi et al.(2) have reported malignancy in 9.3% of lesions ≥20 mm, with 3.3% of invasive carcinomas.

There was no statistical difference when comparing the site of the neoplasms with the occurrence of advanced histology, but all 15 polypoid tumors with advanced histology were located in the left colon, whereas 72.2% (13/18) of non-polypoid neoplasms were in the right colon. This was corroborated by Rondagh et al.(26), who found that proximal neoplasms with advanced histology were more likely to be non-polypoid (OR 4.68, P = 0.006).

In our study, lesions >30 mm were adenomas with high-grade dysplasia or cancer. We have used image magnification for 15 years, and commonly use real or digital chromoscopy. The endoscopic diagnosis of the pit patterns showed good results in terms of sensitivity, specificity and accuracy in the diagnosis of neoplasms, including the case of invasive cancer(17, 21). In previous studies(5, 28), for discriminating between neoplastic and non-neoplastic lesions, we had sensitivity of 97%-97.6%, specificity of 88.9%-93.9%, accuracy of 94.9%-96.8%, positive predictive value of 96.1%-98.4%, and negative predictive value of 91.2%-91.4%.

In this study, only one lesion (1.3%) presented a type II pit pattern, suggestive of a non-neoplastic lesion, however, after endoscopic resection, it was revealed to be a sessile serrated adenoma, a lesion that could be mistaken for a hyperplastic lesion at colonoscopy(10). Among the five lesions with type V pit pattern, histology showed one adenoma with high-grade dysplasia, three intramucosal carcinomas and one invasive carcinoma, which was surgically treated later.

We found a recurrence rate of 10.6%, all of them for non-polypoid LST-type lesions, which underwent endoscopic mucosal resection. In a previous study of colorectal endoscopic mucosal resection, we found a low recurrence rate (4.1%), with a significant association with larger lesion sizes (P<0.01)(6). The screening and the complete removal of colorectal neoplasms is of paramount importance. Robertson et al.(25) have observed 11 cases of CRC in colonoscopic surveillance, possibly associated with incomplete resection of the lesions.


Once analysing our colorectal neoplasms ≥20 mm, 43.4% had advanced histology, but with a low rate of malignancy (5.3%), either for polypoid or non-polypoid lesions, and invasive carcinoma (1.3%). Therefore, endoscopic treatment is an effective therapy for large colorectal neoplasms.


1. Ahlawat SK, Gupta N, Benjamin SB, Al-Kawas FH. Large colorectal polyps: endoscopic management and rate of malignancy: does size matter? J Clin Gastroenterol. 2011;45:347-54. [ Links ]

2. Caputi IO, Ugenti I, Martines G, Marino F, Francesco Altomare D, Memeo V. Endoscopic management of large colorectal polyps. Int J Colorectal Dis. 2009;24:749-53. [ Links ]

3. Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut. 2011;60:1537-43. [ Links ]

4. Consolo P, Luigiano C, Strangio G, Scaffidi MG, Giacobbe G, Di Giuseppe G, et al. Efficacy, risk factors and complications of endoscopic polypectomy: ten year experience at a single center. World J Gastroenterol. 2008;14:2364-9. [ Links ]

5. dos Santos CE, Lima JC, Lopes CV, Malaman D, Salomão AD, Garcia AC, Teixeira CR. Computerized virtual chromoendoscopy versus indigo carmine chromoendoscopy combined with magnification for diagnosis of small colorectal lesions: a randomized and prospective study. Eur J Gastroenterol Hepatol 2010;22:1364-71. [ Links ]

6. dos Santos CE, Malaman D, Pereira-Lima JC. Endoscopic mucosal resection in colorectal lesion: a safe and effective procedure even in lesions larger than 2 cm and in carcinomas. Arq Gastroenterol. 2011;48:242-47. [ Links ]

7. Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press: 2000;104-19. [ Links ]

8. Hassan C, Quintero E, Dumonceau JM, Regula J, Brandão C, Chaussade S, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2013;45:842-51. [ Links ]

9. Ikard RW, Snyder RA, Roumie CL Postoperative Morbidity and Mortality among Veterans Health Administration Patients Undergoing Surgical Resection for Large Bowel Polyps (Bowel Resection for Polyps). Dig Surg. 2013;30:394-400. [ Links ]

10. Ishigooka S, Nomoto M, Obinata N, Oishi Y, Sato Y, Nakatsu S, et al. Evaluation of magnifying colonoscopy in the diagnosis of serrated polyps. World J Gastroenterol. 2012;18:4308-16. [ Links ]

11. Kobayashi N, Saito Y, Uraoka T, Matsuda T, Suzuki H, Fujii T. Treatment strategy for laterally spreading tumors in Japan: before and after the introduction of endoscopic submucosal dissection. J Gastroenterol Hepatol. 2009;24:1387-92. [ Links ]

12. Kudo S, Hirota S, Nakajima T, Hosobe S, Kusaka H, Kobayashi T, et al. Colorectal tumours and pit pattern. J Clin Pathol 1994;47:880-5. [ Links ]

13. Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumours lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14. [ Links ]

14. Kurisu Y, Shimoda T, Ochiai A, Nakanishi Y, Hirata I, Katsu KI. Histologic and immunohistochemical analysis of early submucosal invasive carcinoma of the colon and rectum. Pathol Int. 1999;49:608-16. [ Links ]

15. Luigiano C, Consolo P, Scaffidi MG, Strangio G, Giacobbe G, Alibrandi A, et al. Endoscopic mucosal resection for large and giant sessile and flat colorectal polyps: a single-center experience with long-term follow-up. Endoscopy. 2009;41:829-35. [ Links ]

16. Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832-41. [ Links ]

17. Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol. 2008;103:2700-6. [ Links ]

18. Matsuda T, Fukuzawa M, Uraoka T, Nishi M, Yamaguchi Y, Kobayashi N, et al. Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: a retrospective multicenter study. Cancer Sci. 2011;102:1693-7. [ Links ]

19. Matsuda T, Saito Y, Hotta K, Sano Y, Fujii T. Prevalence and clinicopathological features of nonpolypoid colorectal neoplasms: should we pay more attention to identifying flat and depressed lesions? Dig Endosc. 2010;22:S57-62. [ Links ]

20. Matsuda T, Saito Y, Fujii T, Uraoka T, Nakajima T, Kobayashi N, et al. Size does not determine the grade of malignancy of early invasive colorectal cancer. World J Gastroenterol. 2009;15:2708-13. [ Links ]

21. Matsumoto K, Nagahara A, Terai T, Ueyama H, Ritsuno H, Mori H, et al. Evaluation of new subclassification of type V(I) pit pattern for determining the depth and type of invasion of colorectal neoplasm. J Gastroenterol. 2011;46:31-8. [ Links ]

22. Morson BC. The polyp-cancer sequence in the large bowel. Proceedings of the Royal Society of Medicine. 1974;67:451-57. [ Links ]

23. Reinhart K, Bannert C, Dunkler D, Salzl P, Trauner M, Renner F, et al. Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement. Endoscopy. 2013;45:350-6. [ Links ]

24. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315-29. [ Links ]

25. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2013 Jun 21 (Epub ahead of print). [ Links ]

26. Rondagh EJ, Masclee AA, van der Valk ME, Winkens B, de Bruïne AP, Kaltenbach T, et al. Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential. Scand J Gastroenterol. 2012;47:80-8. [ Links ]

27. Sano Y, Tanaka S, Teixeira CR, Aoyama N. Endoscopic detection and diagnosis of 0-IIc neoplastic colorectal lesions. Endoscopy. 2005;37:261-67. [ Links ]

28. Santos CEO, Pereira-Lima JC, Lopes CV, Malaman D, Parada AA, Salomão AD. Comparative study between MBI (FICE®) and magnification chromoendoscopy with indigo carmine in the differential diagnosis of neoplastic and non-neoplastic colorectal lesions. Arq Gastroenterol. 2009;46:111-15. [ Links ]

29. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008;299:1027-35. [ Links ]

30. Tanaka S, Oka S, Chayama K. Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol. 2008;43:641-51. [ Links ]

31. The Paris endoscopic classification of superficial neoplastic lesions esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3-S43. [ Links ]

32. Uraoka T, Saito Y, Matsuda T, Ikehara H, Gotoda T, Saito D, Fujii T. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut. 2006;55:1592-7. [ Links ]

33. Zauber AG, Winawer SJ, O‘Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-96. [ Links ]

Received: December 22, 2013; Accepted: April 11, 2014

Correspondence: Carlos Eduardo Oliveira dos Santos. Rua Gomes Carneiro, 1343. CEP: 96400-130 - Bagé, RS, Brasil. E-mail:

Declared conflict of interest of all authors: none

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.